登录新浪财经APP 搜索【信披】查看更多考评等级 临近年底，控制权交易暴增。12月以来，已有超20家上市公司披露控制权拟发生变更。 值得一提的是，国资也是频频出手，其中三家收入超100亿元的地方国资拟收购上市公司控制权。 分别是：广西现代物流（收入476亿元）收购东方智造（002175）、江药集团（收入127亿元）收购太龙药业（600222）、荆江实业（收入148亿元）收购 ST易事特（维权）（300376）。 1、2025年12月20日，广西现代物流（子公司物流科技）拟以7.32亿元通过"协议转让14.33%+表决权放弃4.87%"收购东方智造 东方智造控股股东科翔高新拟通过协议转让的方式向现代物流及物流科技出让其持有的东方智造14.33%股份，其中，现代物流和物流科技拟分别受让 9.33%和5.00%股份。 同时，科翔高新承诺自股份过户完成之日起，放弃承诺人持有的东方智造股份4.87%表决权。 本次权益变动后，广西现代物流将成为东方智造控股股东，实际控制人由李斌变更为广西国资委。 物流科技的控股股东为现代物流，实际控制人为广西国资委，现代物流和物流科技的股权控制关系如下： 同时，泰容产投与江药控股将就涉及 ...

Core Viewpoint - Renfu Pharmaceutical (600079.SH) is facing a fine of 17.5 million yuan due to violations associated with its former controlling shareholder, Dongdai Group, marking the end of its historical burdens and paving the way for a "third entrepreneurship" under the control of China Merchants Group [2] Group 1: Company Developments - Renfu Pharmaceutical's stock will be suspended for one day on December 15, 2025, and will be subject to risk warnings starting December 16, 2025, with its A-share name changing to "ST Renfu" [2] - The company reported a revenue of 17.883 billion yuan and a net profit attributable to shareholders of 1.1 billion yuan, marking a year-on-year increase of 6.22%, ending a two-year decline [7] - The company has successfully rectified the violations mentioned in the administrative penalty notice, ensuring that future operations will not be affected [7] Group 2: Industry Context - Dongdai Group, once the largest private enterprise group in Hubei, controlled four A-share listed companies and had total assets exceeding 100 billion yuan before facing a debt crisis [4] - The debt crisis led to the transfer of control of its listed companies to state-owned enterprises, with significant changes in management and operational performance observed post-acquisition [5][6] - Other companies under Dongdai Group, such as Santai Cableway and ST Mingcheng, have shown remarkable recovery in performance after the change in control, with Santai Cableway achieving a revenue increase of 180.67% in 2023 [3][8]